Article Versions Notes

Gurjar P, Karuvantevida N, Rzhepakovsky IV, Khan AA, Khandia R. A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons. Vaccines. 2023; 11(2):487. https://doi.org/10.3390/vaccines11020487

Gurjar, Pankaj, Noushad Karuvantevida, Igor Vladimirovich Rzhepakovsky, Azmat Ali Khan, and Rekha Khandia. 2023. "A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons" Vaccines 11, no. 2: 487. https://doi.org/10.3390/vaccines11020487

Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023). A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons. Vaccines, 11(2), 487. https://doi.org/10.3390/vaccines11020487